Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
Journal of the American Medical Informatics Association : JAMIA
|
April 13, 2020
Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration's Sentinel system
Jeffrey S Brown, Judith C Maro, Michael Nguyen, et al.
Drug Safety
|
February 9, 2019
Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
Efe Eworuke, Emily C Welch, Anne Tobenkin, et al.
American Journal of Epidemiology
|
October 13, 2022
Sequential Data-Mining for Adverse Events After Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic
W Katherine Yih, Martin Kulldorff, Inna Dashevsky, et al.
Pharmacoepidemiology and Drug Safety
|
May 24, 2024
Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment
Ashish Rai, Judith C Maro, Sarah Dutcher, et al.
Journal of Clinical Epidemiology
|
May 21, 2019
Leveraging the entire cohort in drug safety monitoring: part 1 methods for sequential surveillance that use regression adjustment or weighting to control confounding in a multisite, rare event, distributed data setting
Jennifer C Nelson, Ernesto Ulloa-Pérez, Jennifer F Bobb, et al.
Pharmacoepidemiology and Drug Safety
|
April 5, 2014
Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity
Judith C Maro, Jeffrey S Brown, Gerald J Dal Pan, et al.
Journal of General Internal Medicine
|
July 18, 2014
Orphan therapies: making best use of postmarket data
Judith C Maro, Jeffrey S Brown, Gerald J Dal Pan, et al.
EGEMS (Washington, DC)
|
June 9, 2018
Statistical Power for Postlicensure Medical Product Safety Data Mining
Judith C Maro, Michael D Nguyen, Inna Dashevsky, et al.
Pharmacoepidemiology and Drug Safety
|
March 8, 2019
The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies
Andrew B Petrone, April DuCott, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety
|
November 19, 2019
Quantifying how small variations in design elements affect risk in an incident cohort study in claims
Rima Izem, Ting-Ying Huang, Laura Hou, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
Journal of the American Medical Informatics Association : JAMIA
|
April 13, 2020
Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration's Sentinel system
Jeffrey S Brown, Judith C Maro, Michael Nguyen, et al.
Drug Safety
|
February 9, 2019
Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
Efe Eworuke, Emily C Welch, Anne Tobenkin, et al.
American Journal of Epidemiology
|
October 13, 2022
Sequential Data-Mining for Adverse Events After Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic
W Katherine Yih, Martin Kulldorff, Inna Dashevsky, et al.
Pharmacoepidemiology and Drug Safety
|
May 24, 2024
Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment
Ashish Rai, Judith C Maro, Sarah Dutcher, et al.
Journal of Clinical Epidemiology
|
May 21, 2019
Leveraging the entire cohort in drug safety monitoring: part 1 methods for sequential surveillance that use regression adjustment or weighting to control confounding in a multisite, rare event, distributed data setting
Jennifer C Nelson, Ernesto Ulloa-Pérez, Jennifer F Bobb, et al.
Pharmacoepidemiology and Drug Safety
|
April 5, 2014
Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity
Judith C Maro, Jeffrey S Brown, Gerald J Dal Pan, et al.
Journal of General Internal Medicine
|
July 18, 2014
Orphan therapies: making best use of postmarket data
Judith C Maro, Jeffrey S Brown, Gerald J Dal Pan, et al.
EGEMS (Washington, DC)
|
June 9, 2018
Statistical Power for Postlicensure Medical Product Safety Data Mining
Judith C Maro, Michael D Nguyen, Inna Dashevsky, et al.
Pharmacoepidemiology and Drug Safety
|
March 8, 2019
The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies
Andrew B Petrone, April DuCott, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety
|
November 19, 2019
Quantifying how small variations in design elements affect risk in an incident cohort study in claims
Rima Izem, Ting-Ying Huang, Laura Hou, et al.
Page
of 8